BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26090982)

  • 1. Unusual Femur Stress Fractures in Children With Osteogenesis Imperfecta and Intramedullary Rods on Long-term Intravenous Pamidronate Therapy.
    Hegazy A; Kenawey M; Sochett E; Tile L; Cheung AM; Howard AW
    J Pediatr Orthop; 2016; 36(7):757-61. PubMed ID: 26090982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent Proximal Femur Fractures in a Teenager With Osteogenesis Imperfecta on Continuous Bisphosphonate Therapy: Are We Overtreating?
    Vasanwala RF; Sanghrajka A; Bishop NJ; Högler W
    J Bone Miner Res; 2016 Jul; 31(7):1449-54. PubMed ID: 26845496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of an interdisciplinary approach in the healing of long bone fractures in patients with osteogenesis imperfecta].
    Kokavec M; Novorolský K; Pribilincová Z
    Acta Chir Orthop Traumatol Cech; 2008 Jun; 75(3):185-9. PubMed ID: 18601816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid-term Results of Femoral and Tibial Osteotomies and Fassier-Duval Nailing in Children With Osteogenesis Imperfecta.
    Azzam KA; Rush ET; Burke BR; Nabower AM; Esposito PW
    J Pediatr Orthop; 2018 Jul; 38(6):331-336. PubMed ID: 27379783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diaphyseal Femur Fractures in Osteogenesis Imperfecta: Characteristics and Relationship With Bisphosphonate Treatment.
    Trejo P; Fassier F; Glorieux FH; Rauch F
    J Bone Miner Res; 2017 May; 32(5):1034-1039. PubMed ID: 28019684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
    Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
    J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
    Park KT; Lee KB
    Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined two-centre experience of single-entry telescopic rods identifies characteristic modes of failure.
    Cox I; Al Mouazzen L; Bleibleh S; Moldovan R; Bintcliffe F; Bache CE; Thomas S
    Bone Joint J; 2020 Aug; 102-B(8):1048-1055. PubMed ID: 32731828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do femoral fractures in adult patients with osteogenesis imperfecta imitate atypical femoral fractures? A case series.
    Andersen JD; Bünger MH; Rahbek O; Hald JD; Harsløf T; Langdahl BL
    Osteoporos Int; 2019 Feb; 30(2):513-517. PubMed ID: 30448959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta.
    Land C; Rauch F; Glorieux FH
    J Bone Miner Res; 2006 Mar; 21(3):374-9. PubMed ID: 16491284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramedullary fixation using Kirschner wires in children with osteogenesis imperfecta.
    Imajima Y; Kitano M; Ueda T
    J Pediatr Orthop; 2015 Jun; 35(4):431-4. PubMed ID: 25105986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral atypical femur fractures without bisphosphonate exposure.
    Szolomayer LK; Ibe IK; Lindskog DM
    Skeletal Radiol; 2017 Feb; 46(2):241-247. PubMed ID: 27900455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of femoral fracture nonunion after long-term bisphosphonate use.
    Grady MK; Watson JT; Cannada LK
    Orthopedics; 2012 Jun; 35(6):e991-5. PubMed ID: 22691683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical fracture in a child with osteogenesis imperfecta.
    Carpintero P; Del Fresno JA; Ruiz-Sanz J; Jaenal P
    Joint Bone Spine; 2015 Jul; 82(4):287-8. PubMed ID: 25543273
    [No Abstract]   [Full Text] [Related]  

  • 15. Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?
    Ha YC; Cho MR; Park KH; Kim SY; Koo KH
    Clin Orthop Relat Res; 2010 Dec; 468(12):3393-8. PubMed ID: 20865463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complication following intramedullary fixation with a Fixion nail in a patient with osteogenesis imperfecta: a case report.
    Oztürk H; Oztemür Z; Bulut O; Unsaldi T
    Acta Orthop Belg; 2005 Apr; 71(2):227-9. PubMed ID: 16152860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous pamidronate treatment in children with osteogenesis imperfecta.
    Atta I; Iqbal F; Lone SW; Ibrahim M; Khan YN; Raza J
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):653-7. PubMed ID: 25233970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone densitometry in pediatric patients treated with pamidronate.
    Grissom LE; Kecskemethy HH; Bachrach SJ; McKay C; Harcke HT
    Pediatr Radiol; 2005 May; 35(5):511-7. PubMed ID: 15655696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Outcomes of Nonelongating Intramedullary Fixation of the Lower Extremity for Pediatric Osteogenesis Imperfecta Patients: A Meta-analysis.
    Scollan JP; Jauregui JJ; Jacobsen CM; Abzug JM
    J Pediatr Orthop; 2017; 37(5):e313-e316. PubMed ID: 28277468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate Treatment and the Characteristics of Femoral Fractures in Children With Osteogenesis Imperfecta.
    Vuorimies I; Mäyränpää MK; Valta H; Kröger H; Toiviainen-Salo S; Mäkitie O
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1333-1339. PubMed ID: 28323993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.